“Reasons of treatment switching from first generation to second and third generations of TKIs among CML patients in Iraq -Kurdistan region from 2014-2024” (2025) Journal of Carcinogenesis, 24(8s), pp. 360–368. doi:10.64149/J.Carcinog.24.8s.360-368.